Cero Therapeutics is expanding enrollment in an early clinical trial that’s testing its T-cell-based therapy candidate CER-1236, to now include people with hard-to-treat myelofibrosis. The Phase 1/1b CERTAIN-T study (NCT06834282) is a…

Until my myelofibrosis diagnosis, I didn’t really understand invisible illness. I understood pain that comes and goes, the kind most people experience. You pull a muscle, bang your head walking into a door, or…

Treatment with Vonjo (pacritinib) before a stem cell transplant safely eased symptoms and spleen enlargement in people with myelofibrosis, while also allowing most patients to undergo their planned procedure, according to final findings from a…